The adenosine-dependent angiogenic switch of macrophages to an M2-like phenotype is independent of interleukin-4 receptor alpha (IL-4Rα) signaling

Inflammation

Volumn 36, Issue 4, 2013, Pages 921-931

  Ferrante, Christopher James ^a   Pinhal Enfield, Grace ^a   Elson, Genie ^a   Cronstein, Bruce Neil ^b   Hasko, Gyorgy ^a   Outram, Shalini ^a   Leibovich, Samuel Joseph ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

adenosine receptor; alternative activation; IL 4R ; macrophage; TLR

Indexed keywords

ADENOSINE; ARGINASE 1; CD206 ANTIBODY; DECTIN 1; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 4 RECEPTOR ALPHA; LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN ANTIBODY; TOLL LIKE RECEPTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FIZZ1; TRANSCRIPTION FACTOR YM1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; GENE; IL4RALPHA GENE; IN VIVO STUDY; M2A MACROPHAGE; M2D MACROPHAGE; MACROPHAGE; MACROPHAGE ACTIVATION; MALE; MOUSE; NONHUMAN; PHENOTYPE; POLARIZATION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ADENOSINE; ANIMALS; ARGINASE; BETA-N-ACETYLHEXOSAMINIDASES; CELL DIFFERENTIATION; CELLS, CULTURED; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-4 RECEPTOR ALPHA SUBUNIT; LECTINS; LECTINS, C-TYPE; MACROPHAGE ACTIVATION; MACROPHAGES; MALE; MANNOSE-BINDING LECTINS; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; NEOVASCULARIZATION, PHYSIOLOGIC; NITRIC OXIDE SYNTHASE TYPE II; PURINERGIC P1 RECEPTOR AGONISTS; RECEPTOR, ADENOSINE A2A; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

BACTERIA (MICROORGANISMS); MURINAE; MUS;

EID: 84880265532     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-013-9621-3     Document Type: Article

References (40)

1. Gordon, S.; and F.O. Martinez. 2010. Alternative activation of macrophages: Mechanism and functions. Immunity 32: 593-604.
2. Leibovich, S.J.; and R. Ross. 1975. The role of the macrophage in wound repair. A study with hydrocortisone and antimacrophage serum. American Journal of Pathology 78: 71-100.
3. Lucas, T.; et al. 2010. Differential roles of macrophages in diverse phases of skin repair. Journal of Immunology 184: 3964-3977.
4. Galli, S.J.; et al. 2011. Phenotypic and functional plasticity of cells of innate immunity: Macrophages, mast cells and neutrophils. Nature Immunology 12: 1035-1044.
5. Mosser, D.M.; and J.P. Edwards. 2008. Exploring the full spectrum of macrophage activation. Nature Reviews Immunology 8: 958-969.
6. Lawrence, T.; and G. Natoli. 2011. Transcriptional regulation of macrophage polarization: Enabling diversity with identity. Nature Reviews Immunology 11: 750-761.
7. Gordon, S.; and P.R. Taylor. 2005. Monocyte and macrophage heterogeneity. Nature Reviews Immunology 5: 953-964.
8. Mosser, D.M. 2003. The many faces of macrophage activation. Journal of Leukocyte Biology 73: 209-212.
9. Stein, M.; et al. 1992. Interleukin 4 potently enhances murine macrophage mannose receptor activity: A marker of alternative immunologic macrophage activation. The Journal of Experimental Medicine 176: 287-292.
10. Willment, J.A.; et al. 2003. Dectin-1 expression and function are enhanced on alternatively activated and GM-CSF-treated macrophages and are negatively regulated by IL-10, dexamethasone, and lipopolysaccharide. Journal of Immunology 171: 4569-4573.
11. Kreider, T.; et al. 2007. Alternatively activated macrophages in helminth infections. Current Opinion in Immunology 19: 448-453.
12. Martinez, F.O.; et al. 2008. Macrophage activation and polarization. Frontiers in Bioscience 13: 453-461.
13. Pinhal-Enfield, G.; et al. 2003. An angiogenic switch in macrophages involving synergy between Toll-like receptors 2, 4, 7, and 9 and adenosine A(2A) receptors. American Journal of Pathology 163: 711-721.
14. Ferrante, C.J.; and S.J. Leibovich. 2012. Regulation of macrophage polarization and wound healing. Advances in Wound Care 1: 10-16.
15. Csoka, B.; et al. 2012. Adenosine promotes alternative macrophage activation via A2A and A2B receptors. The FASEB Journal 26: 376-386.
16. Murphree, L.J.; et al. 2005. Lipopolysaccharide rapidly modifies adenosine receptor transcripts in murine and human macrophages: Role of NF-kappaB in A(2A) adenosine receptor induction. Biochemical Journal 391: 575-580.
17. Ramanathan, M.; et al. 2009. Differential regulation of HIF-1alpha isoforms in murine macrophages by TLR4 and adenosine A(2A) receptor agonists. Journal of Leukocyte Biology 86: 681-689.
18. Ramanathan, M.; et al. 2007. Synergistic up-regulation of vascular endothelial growth factor (VEGF) expression in macrophages by adenosine A2A receptor agonists and endotoxin involves transcriptional regulation via the hypoxia response element in the VEGF promoter. Molecular Biology of the Cell 18: 14-23.
19. Elson, G.; et al. 2013. Induction of murine adenosine A(2A) receptor expression by LPS: Analysis of the 5′ upstream promoter. Genes Immunology. doi: 10.1038/gene.2012.60.
20. Komohara, Y.; et al. 2011. M2 macrophage/microglial cells induce activation of Stat3 in primary central nervous system lymphoma. Journal of Clinical and Experimental Hematopathology 51: 93-99.
21. Kurahara, H.; et al. 2012. M2-polarized tumor-associated macrophage infiltration of regional lymph nodes is associated with nodal lymphangiogenesis and occult nodal involvement in pN0 pancreatic cancer. Pancreas 42: 155-159.
22. Niino, D.; et al. 2010. Ratio of M2 macrophage expression is closely associated with poor prognosis for angioimmunoblastic T-cell lymphoma (AITL). Pathology International 60: 278-283.
23. Prokop, S.; et al. 2011. M2 polarized macrophages and giant cells contribute to myofibrosis in neuromuscular sarcoidosis. American Journal of Pathology 178: 1279-1286.
24. Ruffell, D.; et al. 2009. A CREB-C/EBPbeta cascade induces M2 macrophage-specific gene expression and promotes muscle injury repair. Proceedings of the National Academy of Sciences of the United States of America 106: 17475-17480.
25. Hasko, G.; et al. 2008. Adenosine receptors: Therapeutic aspects for inflammatory and immune diseases. Nature Reviews. Drug Discovery 7: 759-770.
26. Linden, J. 2001. Molecular approach to adenosine receptors: Receptor-mediated mechanisms of tissue protection. Annual Review of Pharmacology and Toxicology 41: 775-787.
27. Greenhalgh, D.G. 1998. The role of apoptosis in wound healing. The International Journal of Biochemistry & Cell Biology 30: 1019-1030.
28. Rai, N.K.; et al. 2005. Apoptosis: A basic physiologic process in wound healing. The International Journal of Lower Extremity Wounds 4: 138-144.
29. Mylonas, K.J.; et al. 2012. Alternative activation of macrophages by filarial nematodes is MyD88-independent. Immunobiology. doi: 10.1016/j.imbio.2012.07.006.
30. Csoka, B.; et al. 2007. A2A adenosine receptors and C/EBPbeta are crucially required for IL-10 production by macrophages exposed to Escherichia coli. Blood 110: 2685-2695.
31. Nemeth, Z.H.; et al. 2005. Adenosine augments IL-10 production by macrophages through an A2B receptor-mediated posttranscriptional mechanism. Journal of Immunology 175: 8260-8270.
32. Macedo, L.; et al. 2007. Wound healing is impaired in MyD88-deficient mice: A role for MyD88 in the regulation of wound healing by adenosine A2A receptors. American Journal of Pathology 171: 1774-1788.
33. Grinberg, S.; et al. 2009. Suppression of PLCbeta2 by endotoxin plays a role in the adenosine A(2A) receptor-mediated switch of macrophages from an inflammatory to an angiogenic phenotype. American Journal of Pathology 175: 2439-2453.
34. Arnold, L.; et al. 2007. Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis. The Journal of Experimental Medicine 204: 1057-1069.
35. Ricardo, S.D.; et al. 2008. Macrophage diversity in renal injury and repair. The Journal of Clinical Investigation 118: 3522-3530.
36. Wynn, T.A.; and L. Barron. 2010. Macrophages: Master regulators of inflammation and fibrosis. Seminars in Liver Disease 30: 245-257.
37. Willenborg, S.; et al. 2012. CCR2 recruits an inflammatory macrophage subpopulation critical for angiogenesis in tissue repair. Blood 120: 613-625.
38. Zhang, X.; and D.M. Mosser. 2008. Macrophage activation by endogenous danger signals. The Journal of Pathology 214: 161-178.
39. Brancato, S.K.; and J.E. Albina. 2011. Wound macrophages as key regulators of repair: Origin, phenotype, and function. American Journal of Pathology 178: 19-25.
40. Daley, J.M.; et al. 2010. The phenotype of murine wound macrophages. Journal of Leukocyte Biology 87: 59-67.